戻る Agenda
Session 16: NDA Submission, FDA Review, and Action on Applications
Session Chair(s)
Elliott Berger, PHD, MS
President
ETB Regulatory Consulting, United States
- Electronic Submissions
- FDA Review of Applications and Actions on Applications
- Amendments to an Unapproved Application
- Reasons Applications are not Approved PDUFA